Member Info for Richob

Infinis. I think Daewoong and/or Affyxell are working on a therapy.

There is also increased confidence in the MSC approach:

https://www.sciencedirect.com/science/article/pii/S2215017X20303635

Onwards Avacta.

... collaborator in this therapy trial:

https://ichgcp.net/clinical-trials-registry/NCT04535856

Jive turkey.

Onwards Avacta.

https://www.investopedia.com/ask/answers/nasdaq-listing-requirements/

A number of tbings:

1. Some holders don't realise that the end of March is just four weeks away.
2. Any number of news items can arrive before then.
3. The sold shares are being bought by larger orders.
4. A complete lack of understanding about the need for easy testing.
5. Perhaps an immediate need for cash.

More than happy myself to have been adding and also to hear different views to the above.

Each to their own. Hold and buy for me.

Onwards Avacta.

MaatD, a new saw or a new van?

Given that Avacta's own ISO accreditation is due by the end of March, LDA, I also think it is reasonable to presume that the Mologic CE marking is near.

What a boost that will be to the sp and no doubt a massive regret to those selling ahead of it.

In addition, Bruker and BAMS can't be that far away and I think that an Asian manufacturing partner for the LFTs will be announced this month.

The potential news flow here over the next four weeks is incredible and given the budget incentives mentioned earlier as part of a "scientific revolution", Avacta must be well placed to take full advantage.

Onwards Avacta ( T shirt with that on please PL).

... very blue.

If they have shaken you out this morning, all the best.

In terms of buy outs, the chemotherapy market is $56bn per year and the radiopharmaceutical market is $15bn per year as per the recent business update.

Might take a very big offer to persuade Alistair to consider it.

Onwards Avacta.

And looking for a number of people it would appear .....

..... let's think why that might be.

Onwards Avacta.

Increasing revenues across the board, cash in the bank and BAMS, LFTs and AVA6000 still to come plus increased collaborations and rental income from the IP.

No wonder it is calm on here, gmcc.

Onwards Avacta.

... think it is because I have had a pint with my friend ....

https://youtu.be/dsj29y7URNk

This is for you, archangel and anybody else needing to know anything:

https://avacta.com/video-qa-with-alastair-smith-on-recent-business-update/

All the best.

Ddorf actually paid you a compliment.

Oh dear, two posts on AVCT and you don't know who the LFT manufacturers are for your investment.

To help, BBI and Abingdon Health and Mologic and GAD would be worth looking up, or you can review a few RNSs.

It's been such a pleasant day.

Looks like a year ago, Daewoong partnered with Infion in East Java. Interesting twist with regard to halal treatments:

https://www.mk.co.kr/news/english/view/2020/01/47708/

Onwards Avacta.

On the BBC news just now has said that as the vaccines begin to bring down the infection rate we need to ensure that we have a robust test and trace system.

I agree with that.

Onwards Avacta.

Yes, Timster. I reckon order filling yet again at the expense of those that see a drop of 4p rather than see the likely rise if they hold.

All the best.

They have successfully applied to become a manufacturer it would appear:

https://www.cmocro.com/news_detail/Daewoong+Enters+Into+CDMO+Business/560498/index.html

Onwards Avacta.

Vox also said there would be another interview regarding BAMS I believe and let's not forget Daewoong and the $25bn stem cell market.

https://www.thebusinessdesk.com/yorkshire/news/2069536-multi-million-pound-investment-in-next-generation-cell-and-gene-therapies

Onwards Avacta.

These are always at the expense of smaller PIs, which is what we all are.

Do your research and hold and then buy when you can as clearly others have.

Not a ramp, just an observation.

Cave Exigo.

Onwards Avacta.

Firstly, an existing drug works (to whatever degree).

Secondly, this is why there only needs to be phase one and phase two.

The report you have read is about ALL starter treatments, none of which have the IP being used in AVA6000.

Trust this helps.

Onwards Avacta.